Mesothelin-CAR-T Cells Against Cancers
Conditions: Pancreas Cancer; CAR-T Cell Therapy; Mesothelin; Solid Tumor, Adult Intervention: Biological: CAR-T cells Sponsors: Second Affiliated Hospital of Guangzhou Medical University; Fapon Biotherapy Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
Conditions: Acute Lymphoblastic Leukemia, in Relapse; Non-Hodgkin's Lymphoma, Relapsed; Non-Hodgkin's Lymphoma Refractory; Acute Lymphoblastic Leukemia With Failed Remission; B-cell Non Hodgkin Lymphoma; B Cell Leukemia Intervention: Biological: CD19 specific Chimeric Antigen Receptor T Cell Sponsor: Nationwide Children's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials
SURPASS Retrospective Study
Conditions: Breast Cancer; Breast MRI; Neoadjuvant Systemic Therapy; Sentinel Lymph Node Intervention: Procedure: Sentinel lymph node biopsy followed by axillary lymph node dissection Sponsor: Gangnam Severance Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment
Condition: HIV Infection Primary Interventions: Drug: Dasatinib 70 mg; Other: Placebo Sponsors: Fundació Institut Germans Trias i Pujol; Fundación FLS de Lucha Contra el Sida, Enfermedades Infecciosas y Promoción de la Salud y Ciencia; Spanish Clinical Research Network - SCReN; IrsiCaixa; University of Turin, Italy; Instituto de Salud Carlos III; Germa ns Trias i Pujol Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials
CBM in the Context of Exposure for Acrophobia
Condition: Acrophobia Interventions: Behavioral: One session exposure treatment; Behavioral: Sham Cognitive Bias Modification training; Behavioral: Active Cognitive Bias Modification training Sponsors: Ruhr University of Bochum; University Hospital, Essen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials
